Platelet derived growth factor receptor antagonist (BeyondSpring Pharmaceutical)

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NamePlatelet derived growth factor receptor antagonist (BeyondSpring Pharmaceutical)
Drug Alias NameMTLH-001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitors
TargetsPlatelet-derived growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesWuxi MTLH Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeyondSpring Pharmaceuticals IncShanghai Pharmaceuticals Holding Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A